Frontlight ResearchEarly access
Trial site
Scarborough Village
- 10running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Obesity3 trials
- Heart failure2 trials
- Chronic kidney disease1 trial
- COPD1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 41 trial
- Status
- Recruiting8 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- AstraZeneca11 trials
- DalCor Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes5 recruiting
- Obesity3 recruiting
- Chronic kidney disease1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026